Barrington Research Forecasts Strong Price Appreciation for Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems (NASDAQ:MMSI) had its price target boosted by investment analysts at Barrington Research from $106.00 to $109.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s target price points to a potential upside of 39.71% from the company’s previous close.

A number of other equities analysts have also recently weighed in on the company. Needham & Company LLC dropped their price target on Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating on the stock in a research note on Wednesday. Canaccord Genuity Group boosted their price target on Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Weiss Ratings restated a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 29th. BTIG Research assumed coverage on shares of Merit Medical Systems in a research note on Friday, February 6th. They issued a “buy” rating and a $107.00 price objective for the company. Finally, Zacks Research downgraded shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $103.33.

Merit Medical Systems Price Performance

Shares of NASDAQ:MMSI opened at $78.02 on Wednesday. The company has a current ratio of 4.34, a quick ratio of 2.86 and a debt-to-equity ratio of 0.46. The firm’s 50 day moving average is $83.73 and its two-hundred day moving average is $84.89. The firm has a market capitalization of $4.64 billion, a P/E ratio of 36.80, a PEG ratio of 2.15 and a beta of 0.61. Merit Medical Systems has a 52 week low of $76.68 and a 52 week high of $107.27.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. During the same period last year, the company earned $0.93 earnings per share. The company’s quarterly revenue was up 10.9% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Analysts anticipate that Merit Medical Systems will post 3.37 earnings per share for the current year.

Institutional Investors Weigh In On Merit Medical Systems

Institutional investors and hedge funds have recently made changes to their positions in the company. Tudor Investment Corp ET AL bought a new stake in Merit Medical Systems during the 3rd quarter worth about $2,913,050,000. Wellington Management Group LLP increased its stake in Merit Medical Systems by 377.7% in the third quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after purchasing an additional 980,823 shares in the last quarter. Norges Bank acquired a new stake in Merit Medical Systems in the fourth quarter worth $75,957,000. Thrivent Financial for Lutherans boosted its position in shares of Merit Medical Systems by 250.5% during the third quarter. Thrivent Financial for Lutherans now owns 750,066 shares of the medical instruments supplier’s stock worth $62,428,000 after purchasing an additional 536,072 shares in the last quarter. Finally, Iron Triangle Partners LP acquired a new position in shares of Merit Medical Systems in the 4th quarter valued at $33,992,000. Institutional investors own 99.66% of the company’s stock.

Key Headlines Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Q4 results beat expectations: EPS and revenue topped consensus, margins expanded driven by Cardiovascular strength and solid U.S. & EMEA sales — a fundamental driver supporting the stock. Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand
• Positive Sentiment: Barrington Research raised its price target to $109 and maintained an “outperform” rating, signaling bullish analyst conviction that the company can deliver upside from current levels. Barrington Research raises PT to $109
• Positive Sentiment: Management projects 6%–8% revenue growth for 2026 and is divesting the DualCap business to focus on strengthening global platforms—this strategic clarity and growth guide support medium‑term revenue expansion. Merit projects 6%-8% revenue growth for 2026 while divesting
• Neutral Sentiment: Earnings call presentation and detailed slides are available for review — useful for investors digging into segment performance and margin drivers but not new market-moving information on their own. Q4 results presentation
• Neutral Sentiment: Analyst notes and metric comparisons provide context on how the quarter stacks vs. estimates and prior-year numbers—helpful for modeling but not immediately directional. Zacks: Q4 key metrics vs estimates
• Neutral Sentiment: General earnings highlights and recap pieces summarize the beat and guidance for investors who want a quick read. Yahoo Finance earnings highlights
• Neutral Sentiment: Needham kept a Buy rating, citing the strong quarter and outlook, but trimmed its price target to $101 — a mixed signal (positive conviction on fundamentals, smaller near-term upside in the analyst view). TipRanks: Needham maintains Buy, lowers PT
• Negative Sentiment: Wells Fargo downgraded MMSI from Overweight to Equal Weight and cut its price target to $78, signaling reduced near-term conviction and adding selling pressure. Wells Fargo downgrades to Equal Weight

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.